z-logo
open-access-imgOpen Access
Thoracic aortitis and aortic dissection following pegfilgrastim administration
Author(s) -
Yuki Sato,
Shuichiro Kaji,
Hiroyuki Ueda,
Keisuke Tomii
Publication year - 2017
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezx165
Subject(s) - pegfilgrastim , medicine , aortitis , asymptomatic , dissection (medical) , aorta , aortic dissection , thoracic aorta , radiology , surgery , filgrastim , chemotherapy , granulocyte colony stimulating factor
The patient was a 67-year-old woman with a history of advanced lung adenocarcinoma. Eight days after pegfilgrastim administration, her computed tomography scan revealed thickened bilateral common carotid arteries and thoracic aorta, which led to the diagnosis of pegfilgrastim-associated aortitis. Thirty-six days after pegfilgrastim administration, asymptomatic Stanford type B aortic dissection was detected. Her serum biomarker analysis suggested that interleukin-6 might be involved in the pathogenesis. Physicians should be aware of these adverse effects of filgrastim.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom